Loading...

Procaps Group S.A.

PROCF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.03
$-0.07(-74.90%)
U.S. Market opens in 14h 23m

Procaps Group S.A. (PROCF) Stock Overview

Explore Procaps Group S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap57.8M
P/E Ratio0.06
EPS (TTM)$-0.68
ROE-2.24%
Fundamental Analysis

AI Price Forecasts

1 Month$0.14
3 Months$1.07
1 Year Target$0.62

PROCF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Procaps Group S.A. (PROCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.90, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.62.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.06 and a market capitalization of 57.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-74.90%
5-Day Change
-74.90%
1-Month Change
3.72%
3-Month Change
N/A
6-Month Change
-98.21%
Year-to-Date (YTD) Change
N/A
1-Year Change
-98.27%
3-Year Change
-99.41%
5-Year Change
-99.74%
All-Time (Max) Change
-99.74%

Contact Information

https://www.procapsgroup.com
356 7995 6138
9 Rue de Bitbourg, Luxembourg City, NaN, 1273

Company Facts

5,000 Employees
IPO DateOct 4, 2021
CountryLU
Actively Trading

Frequently Asked Questions